PE  Liberty Partners

http://www.libertypartners.com





     Office Locations:

750 Third Avenue, 9th Floor
New York, NY 10017
Phone: 212-541-7676
Fax: 212-649-6076

 

Stages:

  • Middle Market


 

Industries:

  • Business Services
  • Education & Training
  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial

  •  

    Description:

    Liberty Partners specializes in middle-market private equity investments in manufacturing, business services, and education-related companies. Since its founding in 1992, the firm has committed over $1 billion to more than 45 investments. Liberty typically seeks to deploy $20 million to $75 million of equity for controlling or substantial-minority positions in North American-based companies through a range of transaction structures. The firm is specifically interested in opportunities with the following attributes: Revenues of $40+ million, EBITDA of $6+ million, and Transaction value of $35 million to $250 million. The firm does not maintain a minimum size for add-on opportunities. Target industries include niche manufacturing, business services, healthcare, low-medium technology, and education (K-12, post-secondary, corporate training, etc.). To date, the firm has completed more than 45 management buyouts, recapitalizations, and growth investments and currently manages a portfolio of 23 active investments.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Michael J. Fram Managing Director
    Ryan J. Chorazy Vice President

     

    Portfolio companies include:


      Allscrips
        web link


      Arcade


      Behr
        web link


      Chartwell Education Group
        web link


      Component Hardware Group
        web link


      Concorde Career Colleges
        web link


      ConnectiCare
        web link


      Crtikon
        web link


      Datamax
        web link


      Edgenet
        web link


      Edison Schools
        web link


      Fortress Technologies
        web link


      HealthX
        web link


      Henly-Putnam University
        web link


      High Tower Software
        web link


      Internet Healthcare Group
        web link


      Lumenos
        web link


      Monaco Coach
        web link


      NetMotion Wireless
        web link


      NetQoS
        web link


      P.A.S.C.
        web link


      PlayPower
        web link


      Polaris Pool Systems
        web link


      Precyse Solutions
        web link


      RathGibson
        web link


      Regulus Group
        web link


      Rudolph Technologies
        web link


      Seawave
        web link


      Shelton Ogle Enterprises
        web link


      Sigaba
        web link


      SmileCare
        web link


      Source Technologies
        web link


      Step2
        web link


      Technical Concepts
        web link


      YTI Career Institute
        web link


     

    Recent News: